|
1
|
Mundy GR: Metastasis to bone: causes,
consequences and therapeutic opportunities. Nat Rev Cancer.
2:584–293. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Coleman RE and Rubens RD: The clinical
course of bone metastases from breast cancer. Br J Cancer.
55:61–66. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wingo PA, Tong T and Bolden S: Cancer
statistics. Cancer J Clin. 45:8–30. 1995.
|
|
4
|
Liu H, Liu G, Bao Q, et al: The baseline
ratio of neutrophils to lymphocytes is associated with patient
prognosis in rectal carcinoma. J Gastrointest Cancer. 41:116–120.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yamanaka T, Matsumoto S, Teramukai S,
Ishiwata R, Nagai Y and Fukushima M: The baseline ratio of
neutrophils to lymphocytes is associated with patient prognosis in
advanced gastric cancer. Oncology. 73:215–220. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar
|
|
7
|
Satomi A, Murakami S, Ishida K, Mastuki M,
Hashimoto T and Sonoda M: Significance of increased neutrophils in
patients with advanced colorectal cancer. Acta Oncol. 34:69–73.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Walsh SR, Cook EJ, Goulder F, Justin TA
and Keeling NJ: Neutrophil-lymphocyte ratio as a prognostic factor
in colorectal cancer. J Surg Oncol. 91:181–184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu H, Tabuchi T, Takemura A, et al: The
granulocyte/lymphocyte ratio as an independent predictor of tumor
growth, metastasis and progression: its clinical applications. Mol
Med Rep. 1:699–704. 2008.PubMed/NCBI
|
|
10
|
Atzpodien J, Royston P, Wandert T and
Reitz M: Metastatic renal carcinoma comprehensive prognostic
system. Br J Cancer. 88:348–353. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Négrier S, Escudier B, Gomez F, et al:
Prognostic factors of survival and rapid progression in 782
patients with metastatic renal carcinomas treated by cytokines: a
report from the Groupe Francais d'Immunothérapie. Ann Oncol.
13:1460–1468. 2002.
|
|
12
|
Donskov F and von der Maase H: Impact of
immune parameters on long-term survival in metastatic renal cell
carcinoma. J Clin Oncol. 24:1997–2005. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schmidt H, Suciu S, Punt CJ, et al:
Pretreatment levels of peripheral neutrophils and leukocytes as
independent predictors of overall survival in patients with
American Joint Committee on Cancer Stage IV Melanoma: results of
the EORTC 18951 Biochemotherapy Trial. J Clin Oncol. 25:1562–1569.
2007. View Article : Google Scholar
|
|
14
|
Suzuki S, Toyabe S, Moroda T, et al:
Circadian rhythm of leukocytes and lymphocyte subsets and its
possible correlation with the function of the autonomic nervous
system. Clin Exp Immunol. 10:500–508. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mundy GR: Metastasis to bone: causes,
consequences and therapeutic opportunities. Nat Rev Cancer.
2:584–593. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liotta LA and Kohn EC: The
microenvironment of the tumour-host interface. Nature. 411:375–379.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Di Carlo E, Forni G and Musiani P:
Neutrophils in the antitumoral immune response. Chem Immunol
Allergy. 83:182–203. 2003.PubMed/NCBI
|
|
18
|
Schaider H, Oka M, Bogenrieder T, et al:
Differential response of primary and metastatic melanomas to
neutrophils attracted by IL-8. Int J Cancer. 103:335–343. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shamamian P, Schwartz JD, Pocock BJ, Monea
S, Whiting D, Marcus SG and Mignatti P: Activation of progelatinase
A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a
role for inflammatory cells in tumor invasion and angiogenesis. J
Cell Physiol. 189:197–206. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Scapini P, Nesi L, Morini M, et al:
Generation of biologically active angiostatin kringle 1–3 by
activated human neutrophils. J Immunol. 168:5798–5804. 2002.
|
|
21
|
Petrie HT, Klassen LW and Kay HD:
Inhibition of human cytotoxic T lymphocyte activity in vitro by
autologous peripheral blood granulocytes. J Immunol. 134:230–234.
1985.PubMed/NCBI
|
|
22
|
El-Hag A and Clark RA: Immunosuppression
by activated human neutrophils. Dependence on the myeloperoxidase
system. J Immunol. 139:2406–2413. 1987.PubMed/NCBI
|
|
23
|
Shau HY and Kim A: Suppression of
lymphokine-activated killer induction by neutrophils. J Immunol.
141:4395–4402. 1988.PubMed/NCBI
|
|
24
|
Kay HD and Smith DL: Regulation of human
lymphocyte-mediated natural killer (NK) cell activity: inhibition
in vitro by peripheral blood granulocytes. J Immunol. 130:475–483.
1983.PubMed/NCBI
|
